SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Greater China Junior Stocks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Julius Wong who wrote (794)3/17/2005 1:46:42 PM
From: konasurfs1968   of 1992
 
You are most welcome. Glad to see a Greater China stocks board. In regards to DRUG.OB, I am just waiting for the inevitable selloff that happens following reverse merger plays (similar to reverse split plays). When the drop happens, I plan to load up on this China EPO play. Co. now has 1,500 sales people in China to push generic EPO. Should see results of that in a couple of quarters.

I don't know of any other publicly traded generic EPO plays out there, do you? DRUG.OB is very thinly traded. Once revenues of EPO ramp, you just might see some institutional players dipping their feet in. DRUG.OB should already be working on getting off the OTCBB exchange.

Waiting for the s/t weakness, which should happen shortly.

Kind Regards
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext